In the present study, we investigate the pos sible role of protein kinase C (PKC)-dependent smooth muscle contraction in cerebral vasospasm following sub arachnoid hemorrhage (SAH), employing the beagle "two-hemorrhage" model. The occurrence of chronic va sospasm was angiographically confirmed on day 7 in the basilar artery, which was exposed via the transclival ap proach. The artery was superfused with aerated Krebs Henseleit solution containing various agents, and the sub sequent changes in the basilar artery diameter were re corded by successive angiography. The preexisting spasm was not ameliorated by local application of neuro transmitter antagonists (atropine, methysergide, phentol amine, and diphenhydramine), calmodulin inhibitors (R24571 and W-7), or a calcium antagonist, nicardipine. However, the application of PKC inhibitors such as H-7 and staurosporine induced significant dilation of the ar tery. In another experiment, an intrinsic PKC activator,
The refractoriness of chronic vasospasm to va sodilator therapy has been well documented (Bevan and Bevan, 1988) . Particularly, the Ca2+ -antagonist nimodipine, administered via various routes, has in variably failed to reverse chronic vasospasm (Espi nosa et aI. , 1984; Grotenhuis et aI., 1984; Nosko et aI., 1985; Lewis et aI., 1988) . Since agonist-induced smooth muscle contraction has been thought to be dependent on intracellular influx of external Ca2+, 1,2-diacylglycerol (DAG), in the basilar artery, the CSF, and the cisternal clot of beagles exposed to two hemor rhages was measured on days 1, 2,4,7, and 14 using the DAG kinase method. On days 2, 4, and 7, the DAG con tent of the basilar artery showed a significant and pro longed increase (150-190% of control), whereas it was unchanged on days I and 14. Throughout the experimen tal period, there was a significant linear correlation be tween the DAG content and the angiographical diameter of the basilar artery. The above results indicate that SAH leads to an increase in the DAG level within the cerebral artery through an as yet unknown mechanism and that subsequent activation of the PKC-dependent contractile system participates in the occurrence of chronic vaso spasm. Key Words: Cerebral vasospasm-l,2-Diac ylglycerol-H-7-Protein kinase C-Vascular smooth muscle.
it has been conjectured that the primary cause of chronic vasospasm might be the changes in the physical properties in the arterial wall rather than active smooth muscle contraction (Bevan and Be van, 1988; Findlay et aI., 1989; Kim et aI., 1989) .
However, it has recently been shown that during the sustained phase of agonist-induced smooth mus cle contraction, neither the intracellular concentra tion of Ca2+ nor the phosphorylation of myosin light chain is increased (DeFeo and Morgan, 1985; Kamm and Stull, 1985) . To explain the force main tenance during the sustained phase of smooth mus cle contraction, the occurrence of a "latch mechanism" in the myosin-actin interaction has been proposed (Aksoy et aI., 1982 (Aksoy et aI., , 1983 , In keep ing with this line of thinking, Rasmussen et al. (1987) advocated that the sustained smooth muscle contraction is due to phosphorylation of proteins other than myosin light chain by protein kinase C (PKC). This thesis has been supported by numerous succeeding reports, using a variety of arterial smooth muscles (Danthuluri and Deth, 1984; Bara van et ai. , 1985; Forder et ai. , 1985; Chatterjee and Tejada, 1986; Sybertz et ai., 1986; Khalil and van Breemen, 1987) . Our study using the canine basilar artery segment (Sugawa et ai. , 1990) shows that the PKC-mediated contraction elicited by phorbol 12, 13-diacetate is as potent as those induced by prostaglandin F 2 u or serotonin. Of particular rele vance to the issue concerning cerebral vasospasm is the fact that PKC-dependent contraction is only partially dependent on external Ca2+ ; hence, it is not inhibited by application of Ca 2 + channel block ers. The above findings prompted us to undertake a series of experiments to examine whether or not PKC-dependent contraction participates in the oc currence of chronic vasospasm and to see if there is any mechanism within the cerebral artery that leads to sustained PKC activation following subarachnoid hemorrhage (SAH). We herein report that the se vere angiographic narrowing of the canine basilar artery on day 7 of the "two-hemorrhage model" is significantly ameliorated by topical application of PKC inhibitors and that the arterial level of an in trinsic PKC activator, 1,2-diacylglycerol (DAG), is remarkably increased in parallel with the occur rence of chronic vasospasm.
MATERIALS AND METHODS
Experiment 1: topical application of various pharmacological agents to spastic basilar artery Six male beagles were subjected to two hemorrhages (Varsos et aI., 1983) . Briefly, the head of the animal under barbiturate anesthesia was fixed in a stereotaxic frame and the control angiogram was obtained via a catheter inserted into the vertebral artery with the skull in the supine position. Subsequently, the skull was turned to the prone position and the cisterna magna was punctured. Autogenous, fresh, unheparinized arterial blood (0. 4 mV kg) obtained from the femoral artery was substituted for the same amount of CSF. Forty-eight hours after the first injection (day 3), a second angiography was carried out and the cisternal injection of autogenous blood was re peate d in the same fashion.
On d ay 7, when vasospasm in this model is known to become maximal (Watanabe et aI. , 1988) , the animal was anesthetized with sodium pentobarbital (20-30 mg / kg i. v .), transorally intubated, and artificially ventilated following immobilization with intravenous injection of pancuro nium chlori d e. A third angiogram was obtained to deter mine the basilar artery diameter preceding the subsequent procedures. Via the transclival approach, the basilar ar tery was exposed from the junction of vertebral arteries to the bifurcation. The arachnoid membrane and the cis ternal clot around the artery were meticulously removed un d er an operating microscope. After a fourth angiogram
was obtained, the emptied subarachnoid space was filled with the aerated Krebs-Henseleit solution (KHS; in mM: Na 120; KCl 4. 5; CaCl2 2.5; MgCl2 1. 0; NaHC03 27; KH 2 P0 4 1. 0; glucose 10) so that the basilar artery was totally immersed in the solution. The temperature and pH of the KHS were maintained in ranges of 37 ± OSC and 7. 40 ± 0.01, respectively. The KHS in the subarachnoid space was continuously exchanged with the new aerated KHS (10 ml / min) by the use of infusion pumps (Biome dipump, AC 21 20; Perista, Atto, Japan). Twenty minutes after the superfusion with aerated KHS, a fifth angiogram was obtained. The basilar artery was in turn superfused with KHS containing each of the following pharmacolog ical agents: (a) a mixed solution of atropine (10-6 M), M). The artery was exposed to each agent for at least 15 min and the concomitant change in its diameter was re corded by angiography. Prior to application of a new test solution, the subarachnoid space and the basilar artery were washed with KHS and then the artery was allowed to stabilize for 15 min. After the final application of H-7, the artery was washed and superfused with the aerated KHS for 30 min and the last angiogram was obtained. In another experiment, four beagles were subjected to two hemorrhages and the effect of a topical application of staurosporine (10 -9_ 1 0 -7 M) on the angiographic diam eter of the spastic basilar artery was examined according to the method described above. Throughout the above experiments, the systemic arte rial pressure was continuously monitored by a strain gauge transducer (Nihon Kohden, Polygraph System, Ja pan) via a catheter inserted into the femoral artery. Ar terial blood gas was checked (170 pH / Blood Gas Ana lyzer; Corning) and the respiratory condition adjusted so that P0 2 and Pe02 were kept within their normal ranges.
The base excess was corrected by intravenous injection of sodium bicarbonate. The animal was killed by intrave nous administration of an overdose of sodium pentobar bital. With an enlarged projection of each angiogram, the distance between the bifurcation and the vertebrobasilar junction was quartered, and the diameter of the basilar artery was measured at the three intervening points. The mean of these three values represents the basilar artery diameter of each angiogram.
Experiment 2: measurement of the arterial level of DAG A total of 35 male beagles were subjected to two hem orrhages as described above and killed according to the following time schedule: days 0 (normal control; n = 11), 1 (1 h after the first SAH; n = 6), 2 (n = 4),4 (n = 4),6 (n = 6), and 14 (n = 4). Each animal was anesthetized with an intravenous injection of sodium pentobarbital, and angiograms and CSF samples were obtaine d . The animals were then killed by exsanguination from the fem oral artery. The blood within the basilar artery was washed out by perfusion of the lumen via the vertebral artery using aerated KHS. The basilar artery between its bifurcation and the vertebrobasilar junction was then re sected. The cisternal clot around the artery was also col lected. The samples were stored at -80°C until the DAG assay.
The DAG content in each specimen of the CSF, the basilar artery, and the cisternal clot was assayed by the Escherichia coli DAG kinase method described by Preice et al. (1986) . In brief, cellular lipids were extracted by the method of Bligh and Dyer (1959) , dried under nitrogen gas, and incubated in vitro with b-3 2 PlATP and the en zyme, which specifically converts DAG to phosphatidic acid. After separation of phosphatidic acid on a Silica Gel 60 TLC plate (Merck, Darmstadt, F.R.G.), the radioac tivity was counted in a liquid scintillation spectrophotom eter. The amount of DAG in the original sample was cal culated from the radioactivity of b-3 2 PlATP in the reac tion mixture.
Statistical evaluation
Values in the text are shown as means ± SD. Statistical analysis was performed using the Williams-Wilcoxon method to compare variables among the experimental groups. Significance was accepted at the level of 5 % probability.
Chemicals
H-7 and W-7 were purchased from Seikagaku Kogyou Co. Diphenhydramine, R24571, and staurosporine were purchased from Wako Pure Chemical Industries Ltd. , Sigma, and Kyou Medex Co. Ltd., respectively. Phentol amine, methysergide, and nicardipine were kindly sup plied by Ciba Geigy, Sandoz, and Yamanouchi Chemical Co. Ltd.
RESULTS

In vivo effects of pharmacological agents on basilar artery diameter
The mean systemic arterial pressure, Po2, and Peo 2 were maintained within their normal ranges throughout the experiment (Table O. The angiograms performed on days 2 and 7 re vealed a reduction of the mean basilar artery diam eter to 73.0 ± 11.3 and 48.7 ± 6.9% of the control, respectively. On day 14, the basilar artery diameter was increased, coming close to the original caliber prior to SAH (97.5 ± 2.9%).
The ratios of the basilar artery diameter to the normal control (the diameter ratio) following each of surgical manipulation, irrigation with normal KHS, and topical application of drugs were as fol lows: day 0, 100%; day 7, 46.7 ± 9.3%; washout, 48.7 ± 9.4%; neurotransmitter antagonists, 47.8 ± 9.5%; R2457 1, 47.8 ± 9.4%; W-7, 46.7 ± 9.3%; nicardipine (10-7 M), 45.7 ± 9.2%; nicardipine (Fig. O. Impor tantly, the basilar artery diameter was unchanged following surgical manipUlation and irrigation with normal KHS. None of the neurotransmitter antag onists W -7, R2457 1, or nicardipine caused a detect able change in the basilar artery diameter. How ever, H-7 induced a remarkable dilation of the bas ilar artery in a dose-dependent fashion. Upon withdrawal of the agent and irrigation with the nor mal KHS, the basilar artery resumed its diameter prior to drug application. In another series of simi lar experiments, staurosporine was also found to significantly reverse the basilar artery narrowing on day 7 after two hemorrhages. The diameter ratios on day 0 (normal control), on day 7, and following irrigation with KHS and with staurosporine (10-9, 10-8, and 10-7 M) were 100, 53.3 ± 2.5, 50.8 ± 3.8, 57.8 ± 3.8,68.2 ± 11.7, and 78.8 ± 8.5%, respec tively (Fig. 2) .
DAG content of basilar artery and its correlation with basilar artery diameter
The alteration in the DAG content of the basilar artery following two hemorrhages is shown in Fig.  3 , together with the time course of the basilar artery diameter. The DAG content was significantly in creased from day 2 to day 6, in the range of 150--188% of the control. On day 14, the DAG con tent was decreased to a level close to the control. Between the severity of vasospasm and the DAG content in all the specimens examined, a significant linear correlation (r = 0.6864, P < 0.00 1) was re vealed.
DISCUSSION
In the first in vivo experiment, the basilar artery diameter was unaffected by removal of the periar terial subarachnoid clot and irrigation with normal KHS. This result clearly shows that the arterial nar rowing is not due to the direct effects of substances present in the subarachnoid clot or the CSF on the arterial smooth muscle, but to some unknown mechanism operating within the arterial wall or at the interface between the blood and the artery. The antagonists to various neurotransmitters such as norepinephrine, serotonin, histamine, and acetyl choline, or the two different types of calmodulin inhibitors, i.e., R2457 1 (Mills et aI. , 1985) and W-7 (Hidaka et aI., 1978) , did not cause any detectable dilation of the spastic artery. Neither did the Ca2 + antagonist nicardipine. The above result is conso nant with the preceding reports, underscoring the refractoriness of the spastic cerebral artery to var ious vasodilators.
In contrast, PKC inhibitors such as H-7 (Hidaka et aI., 1984) and staurosporine (Tamaoki et aI. , 1986) significantly dilated the spastic basilar artery. This mere fact indicates that the arterial narrowing in chronic vasospasm is not entirely ascribable to organic changes in its wall. Since PKC inhibition is a property common to H-7 and staurosporine, the involvement of the PKC-dependent contractile mechanism in the basilar artery narrowing is strongly suspected. Before such a conclusion is J Cereb Blood Flow Metab, Vol. 11, No.1, 1991 drawn, however, it would be necessary to consider other possible actions of these agents.
H-7 is known to inhibit PKC by interfering with the interaction of ATP and protein substrates within the catalytic domain. In the concentration range used in the present study, the agent also inhibits adenylate-and guanylate-dependent protein kinases (Hidaka et aI., 1984) , which are known to have reg ulatory roles in smooth muscle contraction. Inhibi tion of either system generally leads to augmenta tion of contraction. In particular, 8-bromo-cyclic GMP has been shown to inhibit phorbol 12, 13-diacetate-induced contraction of the beagle basilar artery (Sugawa et aI., 1990) . Therefore, it seems logical to conclude that the observed dilation of the spastic basilar artery reflects mainly PKC inhibition by H-7, although this may be somewhat attenuated by simultaneous inhibition of the guanylate cyclase system. This view is reinforced by the fact that an other type of PKC inhibitor, staurosporine, which interacts directly with the catalytic domain of PKC to exert its effect, similarly dilated the basilar ar tery. Although an unusually high concentration of staurosporine was needed to induce dilation of the spastic basilar artery, this may be due to poor in tracellular penetration of the drug when adminis tered in vivo.
In any event, the implication of our data is that the arterial narrowing in chronic vasospasm is to some or to a large extent due to sustained smooth muscle contraction mediated by PKC. However, since those agents are also effective for protein ki nases other than PKC and may have other nonspe cific effects, the present study does not permit a straightforward interpretation as above. Regarding the participation of the PKC-dependent contractile mechanism in chronic vasospasm, the need for fur ther investigation is obvious. DAG, which is generated together with inositol trisphosphate (IP 3) through hydrolysis of phosphati dylinositoI 4,5-bisphosphate, is an intrinsic activator of PKC (Nishizuka, 1984) . As an indispensable part of our investigation of the presumed role of PKC mediated contraction in the occurrence of chronic vasospasm, we examined the alteration in its con centrations within the canine basilar artery follow ing two hemorrhages. The study revealed a signifi cant increase in the tissue content of DAG on days 2, 4, and 7, corresponding to the period of chronic vasospasm. In the mean values, the increase in the DAG content, as compared with the control, was in the range of 150-188%. This is a relatively large increase considering that the increase in the DAG level in the bovine tracheal smooth muscle chal lenged by carbachol is in the range of 120- 140% FIG. 3 . Changes in the 1,2-diacylglycerol (OAG) content of the basilar artery as compared to al teration of the basilar artery diameter following two hemorrhages. The bars and the points rep resent the OAG content and the diameter ratio, respectively (mean ± SO). The OAG content was significantly increased on days 2, 4, and 7 and thereafter decreased to the control level on day 14. Note the inverse parallel relationship be tween the alterations of the OAG content and the diameter ratio. *p < 0.05, **p < 0.01; '" p < 0.05, .,. ,s. P < 0.01 (Williams-Wilcoxon method). '0 E :l. Takuwa et aI., 1986) . Therefore, the observed in crease in the DAG content within the arterial wall would seem to be sufficient to activate PKC. Fur thermore, the arterial DAG content was decreased to the control level on day 14, in keeping with the disappearance of angiographic vasospasm. The sig nificant correlation between the DAG content and the angiographic diameter of the basilar artery throughout the evolution of vasospasm lends strong support to the view that the PKC-dependent con tractile system activated by an increased DAG level plays a major role in the occurrence of chronic va sospasm. The most interesting corollary of this con cept concerns the mechanism whereby SAH leads to an increase in the arterial DAG level. Some spec ulation on this issue seems to be indicated at this point in order to put our novel thesis in proper per spective.
It has been established that DAG, together with IP3, is generated from the phosphatidylinositol (PI) cycle upon receptor stimulation (Berridge, 1987) . Generally, the activation of the PI cycle upon re ceptor stimulation is only transient. In contrast, the present study revealed a prolonged elevation of the arterial DAG level lasting > 1 week. It is hardly con ceivable that the turnover of the PI cycle is kept in an enhanced state for such a long time span, since the pool of PI is small and PKC activation has been shown to inhibit the receptor-mediated hydrolysis of inositol phospholipids (Nishizuka, 1989 ). Fur- The topical application of antagonists to various neurotransmitters also did not show any significant effect. The implication of these findings is that the spastic artery has developed a mechanism whereby DAG is continuously generated in the absence of receptor stimulation by ambient agonists or neural transmission. Clearly, those aspects of the pre sumed mechanism as described above are inconsis tent with the known properties of the PI cycle.
In this regard, however, it has recently been sug gested that the phosphatidylcholine (PC) cycles take over the role of PI cycle during the sustained phase of cellular response to agonist stimulation. In the PC cycles, DAG generated by the hydrolysis of PC by phospholipases A 2 , C, or D activates mem brane-bound PKC without causing a persistent rise of the intracellular Ca 2 + concentration (Huang, 1989; Pelech and Vance, 1989) . Since the pool of PC is much larger than that of PI, it has been regarded as a potential mechanism underlying the sustained cellular responses and may accordingly be consid ered a candidate for the mechanism involved in the persistent elevation of the arterial DAG level in the spastic cerebral artery. Along this line of thinking, we examined the incorporations of radio labeled ino sitol and choline into PI and PC, respectively, using the arterial segments obtained from the spastic bas ilar artery. The turnover of PC cycles thus far ex amined has been found to be increased by two-to threefold in the spastic artery as compared with the normal, whereas that of the PI cycle was unchanged (unpublished data). Presently, therefore, the PC cy cles may be regarded as the most likely source of DAG generation in the spastic cerebral artery. It is tempting to further speculate that the prolonged en hancement of the PC cycles might be triggered by lipid peroxidation, the occurrence of which follow ing SAH has been fairly well established (Asano et al., 1980; Sasaki et aI., 198 I; Sakaki et aI., 1989) . Degradation of PC by peroxidation propagating within the membrane is considered to provoke re parative responses such as activation of the PC cy cles. Thus, the PC cycles may provide a link be tween lipid peroxidation and PKC activation. This line of thinking may provide a particularly interest ing avenue to explore.
In conclusion, the present study revealed that the severe arterial narrowing in chronic vasospasm was significantly reversed by an in vivo application of PKC inhibitors and that the arterial level of DAG, an intrinsic PKC activator, was significantly in creased in parallel with the occurrence of chronic vasospasm. The possible role of the PKC-depen dent contractile system in the occurrence of chronic vasospasm appears to deserve further investigation. 
